AI assistant
Sending…
Moberg Pharma — Major Shareholding Notification 2014
Jun 30, 2014
3174_iss_2014-06-30_226bbe39-a807-4bf9-af49-cae5cc55f566.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Moberg Pharma AB (publ)
Holder
Wolco Invest AB
Instrument
| Instrument | Common Shares SE0003613090 |
|---|---|
| Before the transaction | |
| Shares | 600,000 |
| Voting rights | 600,000 |
| Transaction | |
| Reason for major shareholding notification Corporate action | |
| Date | 30/06/2014 |
| Limit for number of shares | 5 % |
| Limit for number of votes | 5 % |
| After the transaction | |
| Quantity | |
| Shares | 600,000 |
| Directly held voting rights | 600,000 |
| Indirectly held voting rights | 0 |
| Percentage | |
| Directly held shares | 4.3 % |
| Directly held voting rights | 4.3 % |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | ||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 |
||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled | ||
| - Cash settled | ||
| Total |
Published
30/06/2014 12:27
Contact
Name Wolco Invest AB
Phone 0707357135 Email [email protected]
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Moberg Pharma
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 17
AGM Information
2026
Apr 17
Annual Report
2026
Apr 17
Regulatory Filings
2026
Mar 13